Bisphosphonates - News Articles

CTV Toronto - Are you worried about prescription drug costs? - CTV News


My Dr. wanted me to take Actonel so I called the drug store and asked how much they were. It's a pill for your bones. You take it once a month. One pill was $60.00. Now how out of line is that!!!!! I think these drug stores have some nerve ...
Sanofi layoffs cut total US sales forces to 5,700 - Medical Marketing and Media


Marketing rights for Actonel, a treatment for osteoporosis, were handed off to Warner Chilcott, Sanofi's collaborator on the drug. As part of the deal, Warner Chilcott will offer an undisclosed number of jobs to Sanofi reps previously working on the brand. Actonel sales ...
PharmaLive: GSK announces Q1 results for 2010


The decline in Boniva sales (-63% to £23 million) reflects the transfer on 1st January to Genentech of exclusive promotion of the product in the USA. GSK now records income from Genentech related to the product in Other operating income. ViiV Healthcare, the ...
UPDATE 1-Merck wins federal Fosamax trial | Reuters


VX) Boniva. The drugs are designed to prevent bone fractures and help offset bone loss associated with menopause. Fosamax once generated about $3 billion in annual sales for Merck, but they have plunged since cheaper generic versions of the medicine became available in 2008. ...
Merck: Jury Rules Against Plaintiff Over Fosamax - ABC News


The company says the New York jury ruled unanimously against 69-year-old Louise Maley of Muncie, Ind. She blamed her dental problems on Fosamax, a widely used osteoporosis pill she took for about eight years. Merck says she had multiple medical conditions that ...
Merck & Co restructures cancer drug deal with Ariad, worth up to $583 million; has Fosamax injury case dismissed - Pharmaceutical and Biotechnology News - Pharma Letter


Following an announcement earlier this year by US drug giant Merck & Co that it was reviewing its research priorities as a result of its $41 billion acquisition of Schering-Plough - including its potentially $1 billion deal with Ariad Pharmaceuticals, which caused the latter?s shares to ...
Business news in brief | Philadelphia Inquirer | 05/06/2010


Inc. won a case, the second to go to trial, over allegations its osteoporosis drug Fosamax causes so-called jaw death. Louise Maley of Muncie, Ind., said she developed osteonecrosis of the jaw, or ONJ, by taking Fosamax, in a complaint filed in May 2006. ...
The Associated Press: Merck: Jury rules against plaintiff over Fosamax

Reuters
The company says the New York jury ruled unanimously against 69-year-old Louise Maley of Muncie, Ind. She blamed her dental problems on Fosamax, a widely used osteoporosis pill she took for about eight years. Merck says she had multiple medical conditions that ...
What Is Wegener's Granulomatosis? What Causes Wegener's Granulomatosis?


The following medications may be prescribed: Bisphosphonates (Fosamax) to prevent osteoporosis. Corticosteroids can cause bone loss (osteoporosis). Folic acid - to prevent sores and other problems that can occur when folate levels are low. ...
Irish Medical Times | News | Osteoporosis Society lobbies Minister over drug substitution


including osteoporosis medications and has pointed to several studies which show that switching between bisphosphonates can increase the risk of upper GI events, with one case study of generic switching showing it had potentially contributed to the death of a ...
NCI Cancer Bulletin for April 6, 2010 - National Cancer Institute


Women with breast cancer who received the bone-preserving drug zoledronic acid (Zometa) along with chemotherapy were slightly less likely to have tumor cells detected in their bone marrow several months later than women who received chemotherapy alone. The results , ...
S.A. patients helping test novel bone building therapy for multiple myeloma | kens5.com | San Antonio News, Weather, Sports, Traffic, Entertainment, Video and Photos


It's combined with a drug called Zometa that decreases bone destruction. Padmanabhan says bone scans on test patients revealed an encouraging find, an increase in bone density up to 6%.   There’s no evidence BHQ880 has any ...
Of health and presidential wannabes


truth was it had spread to his bone, which explained his treatment with Zometa, which is not a treatment for prostate cancer but for bone metastasis. And true enough, he died just a little over a year after the elections. ...
BJ's Wholesale Club and Live, Learn and Thrive Donate $100,000 to Local Boys & Girls Clubs – Press Releases on CSRwire.com


Pringles®, Charmin®, Downy®, Lenor®, Iams®, Crest®, Oral-B®, Actonel®, Duracell®, Olay®, Head & Shoulders®, Wella®, Gillette®, Braun® and Fusion®. ...
??? - ????????? ????????

???
??????????????????,?????????????? ??????(Genentech)???,???(Boniva)??????,????????????? ??,???????????????? (http://www.dajiyuan.com) ...
Dog race helps raise money - Fitness - NewsObserver.com


Maybe it was because Sally Field looked so serious talking about staving off brittle bones in those Boniva commercials. Plans for a whitewater park on the ...
Orphan Drug Market Catches Pharma's Eye - Investors.com


Novartis drugs Zometa, Gleevec, Sandostatin and Exjade were launched with orphan status. Their combined estimated sales this year is $8 billion. Other big drugmakers are taking notice. In February, GlaxoSmithKline ( GSK ) announced the launch ...
RN-T.com - Survivor tapped serenity to beat cancer


She's still on maintenance medication and has Zometa infusions every six months, but “I have no worries,” Fergerson said with a smile. And she still participates in the annual Relay For Life fundraiser — as a survivor now instead of as ...
Fracture risk low for women taking long-term bisphosphonate therapy


Merck) in the FIT trial had an HR for subtrochanteric or diaphyseal femur of 1.03 (95% CI, 0.06-16.46), women assigned to zoledronic acid (Zometa, ...
Warner Chilcott Has More Room to Run - Barrons.com


The deal helped to triple Warner's annual sales, dramatically boosted earnings, and added two key drugs -- Actonel and Asacol -- to its lineup. With the patents protecting those medications expiring within four years, investors are growing anxious. But we think ...
Want to contact a Washington, DC Bisphosphonates attorney? ...Get a free case evaluation from one of our Washington, DC Bisphosphonates attorneys now.

Pages: Previous   1   2   3   4   5   6   7   Next

Need A Bisphosphonates Attorney?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Want to contact a Washington, DC Bisphosphonates attorney? ...Get a free case evaluation from one of our Washington, DC Bisphosphonates attorneys now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Bisphosphonates Case - Submit Your Information Below

Do you need legal assistance with your Bisphosphonates case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * Unsafe Drugs: Bisphosphonates Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.